Monoclonal antibodies (mAbs) make up one of the most important classes of advanced biotherapies. To find out about the current challenges and advances in the production of mAbs, GEN talked with Lukas ...

This move aims to establish an indigenous supply, moving away from current imports and scaling up production to a mandated ...

The steady growth of the BCM market is fueled by multiple converging trends. Pharmaceutical and biotechnology companies are ...

A research team led by the University of Delaware’s Kelvin Lee is working to change that. Lee, the Gore Professor of Chemical ...

Danaher’s third quarter was marked by solid execution across its core businesses, with management citing bioprocessing ...

The global Cellbag Bioreactor Chambers market is entering a period of transformative growth, with market value projected to ...

SOUTH SAN FRANCISCO, Calif., Aug. 05, 2025 (GLOBE NEWSWIRE) -- Privately held CHO Plus, Inc. announced today a project agreement awarded from the Biomedical Advanced Research and Development Authority ...

INOVIO (NASDAQ: INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-related diseases, cancer, and infectious diseases, today ...

Important adverse events included infusion-related and hypersensitivity reactions in 25 of 306 immunocompromised participants (8.2%) who received pemivibart and anaphylaxis in 4 of 623 participants (0 ...

Monoclonal gammopathy of undetermined significance (MGUS) is a premalignant plasma-cell disorder present in approximately 5% of the general population over the age of 50 years. MGUS is characterized ...